3,4-dihydroxyphenylacetic acid has been researched along with substance p in 34 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 8 (23.53) | 18.7374 |
| 1990's | 18 (52.94) | 18.2507 |
| 2000's | 8 (23.53) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kam, R; Stöcklin, K; Waldmeier, PC | 1 |
| Hall, ME; Stewart, JM | 1 |
| Huston, JP; Mattioli, R; Schwarting, RK | 1 |
| Adams, F; Boix, F; Huston, JP; Mattioli, R; Schwarting, RK | 2 |
| Hagan, RM; Jones, BJ; Jordan, CC; Tyers, MB | 1 |
| Krause, JE; Sivam, SP | 2 |
| Herrera-Marschitz, M; Hökfelt, T; Ohlin, M; Reid, MS; Ungerstedt, U; Valentino, KL | 1 |
| Brodin, E; Luthman, J; Sundström, E; Wiehager, B | 1 |
| Herrera-Marschitz, M; Kehr, J; Reid, MS; Ungerstedt, U | 1 |
| Chong, PN; de Ceballos, ML; Jenner, P; Marsden, CD; Rose, S; Taylor, MD | 1 |
| Gunne, L; Häggström, JE; Johansson, PE; Terenius, L | 1 |
| Dearmey, P; Fisher, Q; Hall, M; Pelleymounter, MA; Schlesinger, K; Stewart, J | 1 |
| Agid, Y; Benoliel, JT; Cesselin, F; Javoy-Agid, F; Jenner, P; Marsden, CD; Mauborgne, A; Rose, S; Taquet, H | 1 |
| Herrera-Marschitz, M; Hökfelt, T; Reid, M; Terenius, L; Ungerstedt, U | 1 |
| Tan, DP; Tsou, K | 1 |
| Agid, Y; Benoliel, JJ; Javoy-Agid, F; Jenner, P; Legrand, JC; Marsden, CD; Mauborgne, A; Nomoto, M; Rose, S; Taquet, H | 1 |
| Sivam, SP | 1 |
| Bartholini, G; Lloyd, KG; Scatton, B; Worms, P | 1 |
| Beal, MF; Brouillet, E; Henshaw, DR; Hyman, BT; Jenkins, BG; Rosen, BR; Schulz, JB; Sodhi, P | 1 |
| Boix, F; Huston, JP; Nogueira, PJ; Sandor, P; Schwarting, RK | 1 |
| Beal, MF; Brouillet, E; Ferrante, RJ; Hyman, BT; Jenkins, BG; Kowall, NW; Miller, JM; Rosen, BR; Srivastava, R; Storey, E | 1 |
| Humpel, C; Saria, A | 1 |
| Di Giulio, AM; Gorio, A; Malosio, ML; Vergani, L | 1 |
| Abdurasulova, IN; Klimenko, VM; Krasnova, IN; Langel, U; Liudyno, VI | 1 |
| Allouard, N; Bert, L; Bougault, I; Le-Fur, G; Rodier, D; Soubrié, P; Steinberg, R | 1 |
| Nyberg, F; Zhou, Q | 1 |
| Bychkov, ER; Dambinova, SA; Lebedev, AA; Nikolaev, SV | 2 |
| Bychkov, EP; Dambinova, SA; Lebedev, AA; Nikolaev, SV; Obliapin, AV; Shabanov, PD | 1 |
| Bychkov, ER; Dambinova, SA; Lebedev, AA; Nikolaev, SV; Oblyapin, AV; Shabanov, PD | 1 |
| Cox, J; Sivam, SP | 1 |
| de Souza Silva, MA; Huston, JP; Jocham, G; Lauber, AC; Müller, CP | 1 |
34 other study(ies) available for 3,4-dihydroxyphenylacetic acid and substance p
| Article | Year |
|---|---|
Increased dopamine metabolism in rat striatum after infusions of substance P into the substantia nigra.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Caudate Nucleus; Corpus Striatum; Dopamine; Dose-Response Relationship, Drug; Female; Homovanillic Acid; Rats; Receptors, Dopamine; Substance P; Substantia Nigra | 1978 |
The substance P fragment SP(1-7) stimulates motor behavior and nigral dopamine release.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Behavior, Animal; Biogenic Monoamines; Dopamine; Injections, Intraventricular; Male; Motor Activity; Peptide Fragments; Rats; Rats, Inbred Strains; Substance P; Substantia Nigra | 1992 |
Recovery from unilateral 6-hydroxydopamine lesion of substantia nigra promoted by the neurotachykinin substance P 1-11.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Behavior, Animal; Dopamine; Homovanillic Acid; Male; Norepinephrine; Oxidopamine; Rats; Rats, Inbred Strains; Substance P; Substantia Nigra; Sympathectomy, Chemical; Tachykinins | 1992 |
Effects of substance P on extracellular dopamine in neostriatum and nucleus accumbens.
Topics: 3,4-Dihydroxyphenylacetic Acid; Analysis of Variance; Animals; Chromatography, High Pressure Liquid; Corpus Striatum; Dopamine; Homovanillic Acid; Injections, Intraperitoneal; Male; Nucleus Accumbens; Rats; Rats, Inbred Strains; Substance P | 1992 |
Effect of 5-HT3 receptor antagonists on responses to selective activation of mesolimbic dopaminergic pathways in the rat.
Topics: 3,4-Dihydroxyphenylacetic Acid; Amygdala; Animals; Brain; Brain Chemistry; Chromatography, High Pressure Liquid; Dopamine; Electric Stimulation; Hydroxyindoleacetic Acid; Injections; Limbic System; Male; Neural Pathways; Peptide Fragments; Pyrrolidonecarboxylic Acid; Rats; Serotonin Antagonists; Stereotaxic Techniques; Substance P | 1990 |
Compensatory activation of substance P biosynthesis by L-dihydroxyphenylalanine in striatonigral neurons of neonatal dopaminergic denervated rats.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Animals, Newborn; Blotting, Northern; Brain; Dopamine; Female; Injections, Intraperitoneal; Levodopa; Male; Phenylacetates; Protein Precursors; Radioimmunoassay; Rats; Rats, Inbred Strains; RNA, Messenger; Substance P; Tachykinins | 1990 |
Effects of intranigral substance P and neurokinin A on striatal dopamine release--I. Interactions with substance P antagonists.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Corpus Striatum; Dopamine; Drug Interactions; Extracellular Space; Immunohistochemistry; Male; Neurokinin A; Peptide Fragments; Rats; Rats, Inbred Strains; Substance P; Substantia Nigra | 1990 |
Studies on brain monoamine and neuropeptide systems after neonatal intracerebroventricular 6-hydroxydopamine treatment.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Biogenic Amines; Brain; Cerebral Ventricles; Cholecystokinin; Desipramine; Dopamine; Hydroxydopamines; Hydroxyindoleacetic Acid; Injections, Intraventricular; Male; Neuropeptides; Neurotensin; Neurotoxins; Norepinephrine; Organ Specificity; Oxidopamine; Rats; Rats, Inbred Strains; Reference Values; Serotonin; Substance P; Tyrosine 3-Monooxygenase | 1990 |
Striatal dopamine and glutamate release: effects of intranigral injections of substance P.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Corpus Striatum; Denervation; Dopamine; Dopamine Agents; Glutamates; Glutamic Acid; Hydroxydopamines; Male; Oxidopamine; Rats; Rats, Inbred Strains; Substance P; Substantia Nigra | 1990 |
The adaptation of enkephalin, tachykinin and monoamine neurons of the basal ganglia following neonatal dopaminergic denervation is dependent on the extent of dopamine depletion.
Topics: 3,4-Dihydroxyphenylacetic Acid; Adaptation, Physiological; Animals; Animals, Newborn; Basal Ganglia; Biogenic Monoamines; Chromatography, High Pressure Liquid; Denervation; Dopamine; Enkephalin, Methionine; Female; Hydroxydopamines; Hydroxyindoleacetic Acid; Male; Neurons; Nucleic Acid Hybridization; Oxidopamine; Radioimmunoassay; Rats; Rats, Inbred Strains; RNA, Messenger; Serotonin; Substance P | 1990 |
Neuropeptide levels in the basal ganglia of aged common marmosets following prolonged treatment with MPTP.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; 3,4-Dihydroxyphenylacetic Acid; Aging; Animals; Basal Ganglia; Biogenic Monoamines; Callithrix; Caudate Nucleus; Dopamine; Enkephalin, Leucine; Enkephalin, Methionine; Female; Globus Pallidus; Homovanillic Acid; Male; Neuropeptides; Neurotensin; Putamen; Reference Values; Sincalide; Substance P | 1991 |
Neuropeptide changes in a primate model (Cebus apella) for tardive dyskinesia.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Behavior, Animal; Brain Chemistry; Cebus; Corpus Striatum; Disease Models, Animal; Dynorphins; Dyskinesia, Drug-Induced; Female; Globus Pallidus; Glutamate Decarboxylase; Homovanillic Acid; Male; Neuropeptides; Substance P; Substantia Nigra | 1990 |
The effect of substance P and its fragments on passive avoidance retention and brain monoamine activity.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Avoidance Learning; Biogenic Amines; Brain; Dopamine; Hydroxyindoleacetic Acid; Male; Memory; Mice; Peptide Fragments; Retention, Psychology; Serotonin; Substance P | 1986 |
Lack of change in basal ganglia neuropeptide content following subacute 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine treatment of the common marmoset.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; 3,4-Dihydroxyphenylacetic Acid; Animals; Basal Ganglia; Behavior, Animal; Callitrichinae; Caudate Nucleus; Enkephalin, Leucine; Enkephalin, Methionine; Female; Homovanillic Acid; Male; Neuropeptides; Putamen; Pyridines; Sincalide; Substance P | 1986 |
Differential modulation of striatal dopamine release by intranigral injection of gamma-aminobutyric acid (GABA), dynorphin A and substance P.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Chromatography, High Pressure Liquid; Corpus Striatum; Dopamine; Dose-Response Relationship, Drug; Dynorphins; gamma-Aminobutyric Acid; Homovanillic Acid; Injections, Intraventricular; Male; Rats; Rats, Inbred Strains; Substance P | 1988 |
Differential effects of tachykinins injected intranigrally on striatal dopamine metabolism.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Corpus Striatum; Dopamine; Dose-Response Relationship, Drug; Eledoisin; Kassinin; Male; Motor Activity; Rats; Rats, Inbred Strains; Substance P; Substantia Nigra; Tachykinins | 1988 |
Levels of Met-enkephalin, Leu-enkephalin, substance P and cholecystokinin in the brain of the common marmoset following long term 1-methyl-4-phenyl-1,2,3,6,-tetrahydropyridine treatment.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; 3,4-Dihydroxyphenylacetic Acid; Animals; Brain; Callitrichinae; Cholecystokinin; Dopamine; Enkephalin, Leucine; Enkephalin, Methionine; Female; Homovanillic Acid; Male; Organ Specificity; Pyridines; Reference Values; Substance P | 1988 |
Cocaine selectively increases striatonigral dynorphin levels by a dopaminergic mechanism.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Cocaine; Corpus Striatum; Dopamine; Dynorphins; Endorphins; Enkephalin, Methionine; Hydroxyindoleacetic Acid; Neuropeptides; Rats; Receptors, Dopamine; Serotonin; Substance P; Substantia Nigra | 1989 |
Cortical modulation of striatal function.
Topics: 3,4-Dihydroxyphenylacetic Acid; Acetylcholine; Animals; Cerebral Cortex; Choline O-Acetyltransferase; Corpus Striatum; Dopamine; Extrapyramidal Tracts; Frontal Lobe; Glutamate Decarboxylase; Haloperidol; Humans; Male; Motor Activity; Neural Pathways; Rats; Rats, Inbred Strains; Stereotyped Behavior; Substance P; Synaptic Transmission | 1982 |
Systemic or local administration of azide produces striatal lesions by an energy impairment-induced excitotoxic mechanism.
Topics: 3,4-Dihydroxyphenylacetic Acid; Adenosine Triphosphate; Aging; Animals; Azides; Biogenic Amines; Corpus Striatum; Dopamine; Dose-Response Relationship, Drug; Functional Laterality; gamma-Aminobutyric Acid; Glial Fibrillary Acidic Protein; Homovanillic Acid; Injections, Intraperitoneal; Lactates; Magnetic Resonance Imaging; Male; Microinjections; NADPH Dehydrogenase; Neurons; Neuropeptide Y; Neuropeptides; Neurotoxins; Oxidative Phosphorylation; Oxidative Stress; Rats; Rats, Sprague-Dawley; Sodium Azide; Somatostatin; Substance P | 1994 |
Relationship between dopamine release in nucleus accumbens and place preference induced by substance P injected into the nucleus basalis magnocellularis region.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Behavior, Animal; Dopamine; Hydroxyindoleacetic Acid; Male; Microdialysis; Nucleus Accumbens; Rats; Substance P; Time Factors | 1995 |
Peripherally administered substance P affects extracellular dopamine concentrations in the neostriatum but not in the nucleus accumbens under anesthesia.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Dialysis; Dopamine; Homovanillic Acid; Injections, Intraperitoneal; Male; Micromanipulation; Neostriatum; Nucleus Accumbens; Rats; Rats, Wistar; Substance P; Urethane | 1993 |
Neurochemical and histologic characterization of striatal excitotoxic lesions produced by the mitochondrial toxin 3-nitropropionic acid.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Calbindins; Cell Adhesion Molecules, Neuronal; Corpus Striatum; Dopamine; Energy Metabolism; gamma-Aminobutyric Acid; Glial Fibrillary Acidic Protein; Homovanillic Acid; Interneurons; Male; Mitochondria; NADPH Dehydrogenase; Neurons; Neuropeptide Y; Neurotoxins; Nitro Compounds; Propionates; Rats; Rats, Sprague-Dawley; Reference Values; S100 Calcium Binding Protein G; Somatostatin; Substance P | 1993 |
Intranigral injection of selective neurokinin-1 and neurokinin-3 but not neurokinin-2 receptor agonists biphasically modulate striatal dopamine metabolism but not striatal preprotachykinin-A mRNA in the rat.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Corpus Striatum; Dopamine; Female; Gene Expression Regulation; Injections; Neurokinin A; Neurokinin B; Peptide Fragments; Protein Precursors; Rats; Rats, Sprague-Dawley; Receptors, Neurokinin-1; Receptors, Neurokinin-2; Receptors, Neurokinin-3; RNA, Messenger; Substance P; Substantia Nigra; Tachykinins | 1993 |
Exposure to perinatal morphine promotes developmental changes in rat striatum.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Dopamine; Enkephalin, Methionine; Enkephalins; Female; In Situ Hybridization; Lactation; Male; Morphine; Narcotics; Neostriatum; Neurons; Pregnancy; Prenatal Exposure Delayed Effects; Protein Precursors; Rats; Rats, Sprague-Dawley; Receptors, Opioid; RNA, Messenger; Serotonin; Substance P; Synapses; Synapsins; Time Factors; Tyrosine 3-Monooxygenase | 1996 |
[Participation of galaninergic brain structures in response to the systemic lipopolysaccharide administration].
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Body Temperature; Dopamine; Galanin; Homovanillic Acid; Hypothalamus; Lipopolysaccharides; Male; Neuroimmunomodulation; Peptide Fragments; Rats; Rats, Wistar; Receptors, Galanin; Receptors, Neuropeptide; Substance P | 1998 |
Permissive role of neurokinin NK(3) receptors in NK(1) receptor-mediated activation of the locus coeruleus revealed by SR 142801.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Antiemetics; Dose-Response Relationship, Drug; Guinea Pigs; Locus Coeruleus; Male; Neural Pathways; Neurokinin-1 Receptor Antagonists; Neurons; Norepinephrine; Peptide Fragments; Piperidines; Prefrontal Cortex; Pyrrolidonecarboxylic Acid; Receptors, Neurokinin-1; Receptors, Neurokinin-3; Substance P; Tetrazoles | 2002 |
Injection of substance P (SP) N-terminal fragment SP(1-7) into the ventral tegmental area modulates the levels of nucleus accumbens dopamine and dihydroxyphenylacetic acid in male rats during morphine withdrawal.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Dopamine; Extracellular Space; Male; Microdialysis; Morphine Dependence; Naloxone; Narcotic Antagonists; Neural Pathways; Nucleus Accumbens; Peptide Fragments; Presynaptic Terminals; Protein Structure, Tertiary; Rats; Rats, Sprague-Dawley; Substance P; Substance Withdrawal Syndrome; Up-Regulation; Ventral Tegmental Area | 2002 |
[The influence of substance P central administration on ethanol intake in rats chronically exposed to alcohol].
Topics: 3,4-Dihydroxyphenylacetic Acid; Alcohol Drinking; Alcoholism; Animals; Corpus Striatum; Dopamine; Drinking; Homovanillic Acid; Injections, Intraventricular; Male; Nucleus Accumbens; Rats; Rats, Wistar; Substance P | 2002 |
[Effect of centrally administrated substance P on the brain mesolimbic system activity in rats as measured by microdialysis].
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Conditioning, Classical; Dopamine; Dose-Response Relationship, Drug; Homovanillic Acid; Injections, Intraventricular; Limbic System; Male; Microdialysis; Nucleus Accumbens; Rats; Rats, Wistar; Substance P | 2003 |
Mechanisms of the influences of the central administration of substance P on ethanol consumption in chronically alcoholic rats.
Topics: 3,4-Dihydroxyphenylacetic Acid; Alcohol Drinking; Alcoholism; Animals; Dopamine; Ethanol; Homovanillic Acid; Injections, Intraventricular; Male; Neostriatum; Nucleus Accumbens; Rats; Rats, Wistar; Substance P | 2003 |
The effects of substance P after central administration on the activity of the mesolimbic system of the rat brain as studied by microdialysis.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Brain Chemistry; Dopamine; Dose-Response Relationship, Drug; Homovanillic Acid; Injections, Intra-Articular; Male; Microdialysis; Nucleus Accumbens; Rats; Rats, Wistar; Reaction Time; Substance P; Time Factors | 2004 |
Postnatal administration of D1 dopamine agonist reverses neonatal dopaminergic lesion-induced changes in striatal enkephalin and substance P systems.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; 3,4-Dihydroxyphenylacetic Acid; Adrenergic Agents; Animals; Animals, Newborn; Corpus Striatum; Dopamine; Drug Interactions; Enkephalins; Female; Gene Expression; Humans; Male; Oxidopamine; Pregnancy; Quinpirole; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D1; Receptors, Dopamine D2; Substance P | 2006 |
Neurokinin 3 receptor activation potentiates the psychomotor and nucleus accumbens dopamine response to cocaine, but not its place conditioning effects.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Behavior, Animal; Cocaine; Conditioning, Psychological; Dopamine; Dopamine Uptake Inhibitors; Locomotion; Male; Microdialysis; Motor Activity; Nucleus Accumbens; Peptide Fragments; Random Allocation; Rats; Rats, Wistar; Receptors, Neurokinin-3; Substance P | 2007 |